|
ZNF169 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.177800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.113600E-01 |
| Normal-vs-Stage2 |
1.587780E-01 |
| Normal-vs-Stage3 |
4.334200E-01 |
| Normal-vs-Stage4 |
4.089400E-01 |
| Stage1-vs-Stage2 |
3.634200E-01 |
| Stage1-vs-Stage3 |
1.283640E-02 |
| Stage1-vs-Stage4 |
5.943000E-01 |
| Stage2-vs-Stage3 |
7.254400E-02 |
| Stage2-vs-Stage4 |
9.706800E-01 |
| Stage3-vs-Stage4 |
3.040200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.718400E-02 |
| Normal-vs-AfricanAmerican |
1.932440E-01 |
| Normal-vs-Asian |
6.700800E-01 |
| Caucasian-vs-AfricanAmerican |
9.559000E-01 |
| Caucasian-vs-Asian |
3.529600E-01 |
| AfricanAmerican-vs-Asian |
3.983200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.122600E-01 |
| Normal-vs-Female |
9.753900E-02 |
| Male-vs-Female |
6.393600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.491200E-01 |
| Normal-vs-Extreme_Weight |
5.269600E-01 |
| Normal-vs-Obese |
9.508000E-02 |
| Normal-vs-Extreme_Obese |
8.938600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.526000E-01 |
| Normal_Weight-vs-Obese |
6.414000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.037800E-01 |
| Extreme_Weight-vs-Obese |
2.292800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.720600E-01 |
| Obese-vs-Extreme_Obese |
3.987000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.390200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.278500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.522600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.283000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.443000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.439200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.206200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.563600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.895400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.283700E-03 |
| Normal-VS-Type2 PRCC |
2.656600E-01 |
| Normal-VS-KIRP CIMP |
5.957600E-01 |
| Normal-VS-Unclassified PRCC |
1.229630E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.54814999999697E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.742200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.949400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.597600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.397500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.617000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.288600E-01 |
| Normal-vs-N1 |
2.828400E-01 |
| Normal-vs-N2 |
7.009800E-01 |
| N0-vs-N1 |
2.092000E-01 |
| N0-vs-N2 |
7.801600E-01 |
| N1-vs-N2 |
1.660000E-01 |
|
|
